Benefit and Application of β-blocker Therapy for Patients with AMI in the Era of PCI / 沈阳医学院学报

ABSTRACT

[ Abstrct] Back in the 1980s, β?blockers was widely used because of decreased myocardial infarction mortality and protected heart function. In recent years, with the rapid development of percutaneous coronary intervention ( PCI) technology, the mortality of pa?tients with acute myocardial infarction ( AMI) significantly decreased. The issue of whether patients with AMI continue to benefit fromβ?blockers treatment is disputed. This review is aim to retrospect the researches about the effects ofβ?blockers on patients with AMI in aspects of myocardial infarct size, heart failure and mortality after AMI, meanwhile summarizing the rational use ofβ?blocker therapy in the PCI era.